Latest news with #Spinach
The Guardian
2 days ago
- Health
- The Guardian
We should all be eating 30 different plants a week. I can't even name that many
The first mention of five-a-day, as a fruit and vegetable diet ideal was in California in the late 80s, but didn't reach the chattering crudité classes until the mid-90s. I once wrote a food diary for a magazine, in which it turned out I'd had one vegetable across the space of a week, when someone in a cafe slipped some spinach under my fried egg. Eating five a day was harder than it looked, particularly if you didn't like tomatoes and hated fruit. There was a bit of debate around whether potatoes counted (they don't), whether bananas and avocados were false friends (nobody ever got to the bottom of that) and how much lettuce counted as a portion, given that it is basically air. Later, there was a little consternation at how much influence had been wielded by the fruit and vegetable industry. But the late, much-missed Michael Mosley made the adjudication in 2013 that the advice was pretty solid, and that was considered a good enough reason to follow the rule (at least for people who had the budget and headroom to follow rules). So, of course, with all its controversies having been leached out of it by the passage of time, all its strictures being not that strict, five-a-day was bound to be torched by rebels sooner or later, and in 2018 – again, it's taken a while to percolate – the rule became to eat 30 different plants a week. The immediate problem is naming 30 different plants, never mind eating them. I tried it alphabetically and timed out at 'carrot'. Seeds are also considered a plant, and herbs and spices count, but only to the value of a quarter of a point, so now you have a maths challenge, on top of everything else. The lesson here is: don't surrender. The minute we're all eating 30 different plants, the new normal will be 60. You'll soon be foraging for nettles. Zoe Williams is a Guardian columnist Do you have an opinion on the issues raised in this article? If you would like to submit a response of up to 300 words by email to be considered for publication in our letters section, please click here.
Yahoo
3 days ago
- Business
- Yahoo
Cronos Group (CRON) Posts Double-Digit Cannabis Growth and Expands International Footprint
We recently published . Cronos Group Inc. (NASDAQ:CRON) is one of the best healthcare stocks. Cronos Group Inc. (NASDAQ:CRON) is a global cannabis company operating primarily in Canada and Israel, with recognized brands like PEACE NATURALS and Spinach. The company focuses on both medicinal and recreational cannabis markets and is expanding internationally into Australia, Malta, Germany, and Switzerland. In Q2 2025, Cronos Group Inc. (NASDAQ:CRON) reported a 21% year-over-year revenue increase to $33.5 million, driven mainly by its PEACE NATURALS brand in Israel and other international markets. Despite a net loss of $38.5 million influenced partly by foreign exchange impacts, the consolidation of its Canadian cultivation subsidiary, Cronos GrowCo, contributed $2.2 million in flower sales and helped boost gross margins from 23% to 43%. The business strategically focuses on global markets like Israel to offset U.S. regulatory uncertainties and recently resolved an anti-dumping dispute there, stabilizing its international operations. The corporation maintains a strong liquidity position with $834 million in cash and short-term investments, supporting initiatives like an $18.5 million convertible loan investment in Canadian retailer High Tide Inc. Looking ahead, analysts expect profitability to improve with a 50% capacity increase at GrowCo, supporting rising demand and better margins. Q3 2025 revenue is forecasted at $37.3 million with adjusted EBITDA rising to $5.6 million, reflecting operational momentum. Additionally, Cronos Group Inc. (NASDAQ:CRON) announced a $50 million share repurchase program, signaling confidence in its growth prospects. While we acknowledge the potential of CRON as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
RTÉ News
02-08-2025
- Health
- RTÉ News
Mixed leaves and spinach among eight products recalled over listeria
Batches of eight spinach, mixed leaves, rocket and lettuce products sold in Irish supermarkets have been recalled due to the detection of listeria monocytogenes. The Food Safety Authority of Ireland (FSAI) has issued alerts for batches of eight different products. The eight products being recalled are: Egan's Irish Baby Spinach, 250g, with best before dates of 30/07/2025, 31/07/2025 and 01/08/2025 and batch code: 206. McCormack Family Farms Lettuce, 200g, with best before dates: 02/08/2025, 03/08//2025, 09/08/2025 and 10/08/2025 and batch codes: 205, 212. McCormack Family Farms Mixed Leaves, 75g, with best before dates: 26/07/2025, 27/07/2025, 29/07/2025, 31/07/2025, 01/08/2025, 02/08/2025 and 03/08/2025 and batch codes: 199, 202, 204, 205, 206, 207. McCormack Family Farms Rocket, 75g, with best before dates: 31/07/2025 and 03/08/2025 and batch codes: 204, 206. McCormack Family Farms Spinach, 100g, 200g and 250g, with best before dates: 01/08/2025, 02/08/2025, 03/08/2025 and 04/08/2025 and batch codes: 205, 206, 207. McCormack Family Farms Energise Mix, 100g, with best before dates: 28/07/2025, 29/07/2025, 30/07/2025 and 03/08/2025 and batch codes: 199, 203, 205. SuperValu Spinach, 250g, with best before dates: 01/08/2025 and 03/08/2025 and a batch code: 206. Tesco Mild Spinach, 350g, with best before date: 02/08/2025 and batch code: 206. The FSAI has requested that retailers remove the implicated products from sale, and display recall notices at point-of-sale. Wholesalers and distributors are being asked to contact their affected customers and recall the affected products and put a recall notice in place. Caterers who may be in possession of the impacted products have been asked not to use them. Consumers are advised not to eat the implicated products. The FSAI has said there is currently "no evidence that this food recall is linked with the listeriosis outbreak related to ready-to-heat meals that is currently under investigation". The FSAI's latest update follows a recall on Monday of two further spinach products sold in Irish supermarkets with with seven spinach and mixed leaves products having been recalled previously. The authority said that one person with a confirmed case of listeria died, while nine other cases were identified as of late last month. The FSAI said that symptoms of listeria can include mild flu-like symptoms such as gastrointestinal symptoms such as nausea, vomiting and diarrhoea. Symptoms can be more severe in rare cases, it added. "Some people are more vulnerable to listeria monocytogenes infections, including pregnant women, babies, and people with weakened immune systems, including the elderly. "The incubation period (time between initial infection and first symptoms appearing) is on average three weeks but can range between 3 and 70 days," said the FSAI.
Yahoo
02-08-2025
- Business
- Yahoo
Cronos Group Inc. (CRON) Invests $30M in High Tide to Fuel Canadian Cannabis Retail Expansion
We recently compiled a list of the 12 Cheap Pot Stocks to Buy According to Hedge Funds. Cronos Group Inc. stands second on our list. Cronos Group Inc. (NASDAQ:CRON) is a Canadian global cannabinoid company engaged in the cultivation, production, and marketing of cannabis products across Canada, Israel, and other international markets, with brands like Spinach, Lord Jones, and PEACE NATURALS. A key recent development is Cronos Group Inc. (NASDAQ:CRON)'s $30 million convertible debt financing to High Tide Inc., a major cannabis retailer. This junior secured loan supports High Tide's expansion plans to grow its store network beyond 300 locations in Canada and fund acquisitions. The loan carries 4% interest and includes options to convert debt into equity and warrants, reflecting a strategic partnership aimed at strengthening retail presence and enhancing market access for Cronos's products. The corporation is set to report its Q2 2025 earnings on August 7, providing updates on operational progress and strategic outlook. The company has shown solid revenue growth of 27.6%, signaling effective expansion in a competitive market. While not paying dividends, the business focuses on reinvesting for growth, with analysts holding a cautious hold/buy stance. A lab technician meticulously measuring and mixing ingredients to create a cannabis-infused edible. This investment in High Tide marks a strategic emphasis on retail partnerships to improve market penetration and consumer access. By aligning closely with a leading retailer, Cronos Group Inc. (NASDAQ:CRON) aims to capture more market share and curb illicit cannabis sales. The convertible debt structure suggests potential for deeper collaboration or equity stakes, positioning both companies for mutual growth as retail distribution becomes increasingly critical in the cannabis industry. While we acknowledge the potential of CRON as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Hamilton Spectator
25-07-2025
- Business
- Hamilton Spectator
Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025
TORONTO, July 25, 2025 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ('Cronos' or the 'Company') will hold its 2025 second quarter earnings conference call on Thursday, August 7, 2025 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at . To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be archived for replay on the Company's website. About Cronos Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos' diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: . Forward-looking Statements This press release may contain information that may constitute 'forward-looking information' or 'forward-looking statements' within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, 'Forward-looking Statements'). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as 'may', 'will', 'expect', 'plan', 'anticipate', 'intend', 'potential', 'estimate', 'believe' or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about Cronos' intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, each of which have been filed on SEDAR+ and EDGAR and can be accessed at and , respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement. Cronos Contact Harrison Aaron Investor Relations Tel: (416) 504-0004
